Biotest GmbH KGaA (LTS:0N6Z) Market Cap: £0.00 Mil (As of Aug. 11, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Biotest GmbH KGaA Market Cap?

Biotest GmbH KGaA LTS:0N6Z Market Cap is £0.00 Mil as of Aug. 11, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Biotest GmbH KGaA's share price for the quarter that ended in . 20 was £. Biotest GmbH KGaA's Shares Outstanding (EOP) for the quarter that ended in . 20 was 0.00 Mil. Therefore, Biotest GmbH KGaA's market cap for the quarter that ended in . 20 was £ Mil.

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Biotest GmbH KGaA's Enterprise Value for Today is £0.00 Mil.

Biotest GmbH KGaA  (LTS:0N6Z) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Biotest GmbH KGaA Market Cap Related Terms

Biotest GmbH KGaA Market Cap Historical Data

* Premium members only.

The historical data trend for Biotest GmbH KGaA's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotest GmbH KGaA Market Cap Chart

Biotest GmbH KGaA Annual Data
Trend
Market Cap

Biotest GmbH KGaA Semi-Annual Data
Market Cap

LTS:0N6Z vs : Market Cap Comparison

For the Biotechnology subindustry, Biotest GmbH KGaA's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotest GmbH KGaA Market Cap vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biotest GmbH KGaA's Market Cap distribution charts can be found below:

* The bar in red indicates where Biotest GmbH KGaA's Market Cap falls into.


Biotest GmbH KGaA Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Biotest GmbH KGaA's Market Cap for the fiscal year that ended in . 20 is calculated as

Market Cap (A: . 20 )=Share Price (A: . 20 )*Shares Outstanding (EOP) (A: . 20 )
=£*
=£

Biotest GmbH KGaA's Market Cap for the quarter that ended in . 20 is calculated as

Market Cap (Q: . 20 )=Share Price (Q: . 20 )*Shares Outstanding (EOP) (Q: . 20 )
=£*0
=£

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of £0.00 Mil mean?
Biotest GmbH KGaA (LTS:0N6Z) has a Market Cap of £0.00 Mil as of Aug. 11, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Biotest GmbH KGaA and its competitors.
Is Biotest GmbH KGaA's Market Cap too high?
Biotest GmbH KGaA's current Market Cap is £0.00 Mil.
How does Biotest GmbH KGaA's Market Cap compare to ?
Biotest GmbH KGaA's Market Cap of £0.00 Mil can be compared against companies in the Biotechnology industry. The industry median Market Cap is 116.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 116.29, based on 1,420 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Biotest GmbH KGaA and its competitors. For the Biotechnology industry, the median Market Cap is 116.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biotest GmbH KGaA's current Market Cap is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biotest GmbH KGaA stock overvalued right now?
Biotest GmbH KGaA (LTS:0N6Z) has a current Market Cap of £0.00 Mil. The current Market Cap is £0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Biotest GmbH KGaA (LTS:0N6Z), the current Market Cap is £0.00 Mil as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biotest GmbH KGaA Business Description

Comparable Companies
Biotest GmbH & Co KGaA is a specialist in haematology, clinical immunology, and intensive care medicine. The group develops, manufactures, and markets plasma proteins and biotherapeutic drugs. The group's value chain extends from pre-clinical and clinical development to world-wide marketing and distribution. It manufactures immunoglobulins, clotting factors, and albumins, which are derived from human blood plasma. The group markets its products in Europe, the Middle East, China, Australia, Africa, and the USA.